Description

(3Beta,5Beta)-3-[(2,6-Dideoxy-4-o-β-D-Glucopyranosyl-β-D-Ribo-Hexopyranosyl)Oxy]-5,14-Dihydroxy-19-Oxocard-20(22)-Enolide CAS NO 7082-34-0 is a high-purity cardiac glycoside derivative, a class of compounds known for their potent and specific biological activity. This compound is critical for pharmaceutical research and development, particularly in the study of cardiac function and the development of novel therapeutic agents. It is primarily utilized by research institutions, pharmaceutical manufacturers, and biotechnology companies engaged in cardiovascular drug discovery and biochemical analysis.

Application

• Pharmaceutical Reference Standard: Serves as a certified reference material (CRM) for quality control and analytical method development in drug manufacturing.
• Cardiovascular Research: Used as a key biochemical tool in in vitro and in vivo studies to investigate ion channel function, myocardial contractility, and heart failure mechanisms.
• Active Pharmaceutical Ingredient (API) Intermediate: Acts as a crucial synthetic precursor or intermediate in the production of specialized cardiac medications.
• Biochemical Assay Development: Employed in the calibration and validation of diagnostic assays and screening platforms targeting Na+/K+-ATPase activity.
• Academic & Institutional Research: Supports fundamental research in pharmacology, medicinal chemistry, and molecular biology within university and government laboratories.

Basic Information

Product Name	(3Beta,5Beta)-3-[(2,6-Dideoxy-4-o-β-D-Glucopyranosyl-β-D-Ribo-Hexopyranosyl)Oxy]-5,14-Dihydroxy-19-Oxocard-20(22)-Enolide
CAS No.	7082-34-0
Molecular Formula	C35H54O14
Molecular Weight	698.80 g/mol
Synonyms	Digitoxigenin β-D-digitoxoside; 3β-[(2,6-Dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-5β,14β-dihydroxy-19-oxocard-20(22)-enolide; β-Acetyldigoxin aglycone glycoside; Strophanthidin derivative; Cardiac aglycone glycoside; 19-Oxocard-20(22)-enolide, 3-[(2,6-dideoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-, (3β,5β)-; 7082-34-0
EINECS	Contact for details

Quality Control

Every batch of our (3Beta,5Beta)-3-[(2,6-Dideoxy-4-o-β-D-Glucopyranosyl-β-D-Ribo-Hexopyranosyl)Oxy]-5,14-Dihydroxy-19-Oxocard-20(22)-Enolide is manufactured and tested under a strict quality management system. We provide comprehensive analytical documentation, including a Certificate of Analysis (COA) detailing purity, identity, and impurity profiles as determined by HPLC, NMR, and MS. Our quality protocols are designed to meet the stringent requirements of pharmaceutical research and development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a desiccated environment to maintain stability and purity. For long-term storage, consider inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.